Transforming medical imaging for early disease detection
We are pioneering the power of molecular imaging with MRI.
We are developing new ways — based on our proprietary nanoparticle technology — to allow doctors to identify the presence of cancer sooner and more specifically than current methods.
We aspire to provide the tools to detect cancer at an earlier stage when treatment is most effective.
MagSense® Imaging Agent Technology
Simple, bio-safe molecular imaging
How does MagSense® imaging technology work?
How is MagSense® better than other imaging methods?
How will MagSense® change cancer detection?
MagSense® Phase 1 Study – HER2 Breast Cancer
MagSense® HER2 Clinical Trial
Our novel MagSense® HER2 imaging agent using bio-safe magnetic nanoparticles is being tested to show whether it has the potential to non-invasively detect the spread of breast cancer to the regional lymph nodes, avoiding the need for intrusive biopsies.
We have completed enrolling patients in a multi-site Phase I study of the MagSense® HER2 imaging agent.
PrecisionMRX® Nanoparticles
Nanoparticles that can save lives
In addition to their use in our MagSense® technology for cancer detection using MRI (magnetic resonance imaging), our proprietary PrecisionMRX® nanoparticles can be used in a number of other applications, including MPI (magnetic particle imaging), magnetically induced hyperthermia and others.
Read about the other ways PrecisionMRX® nanoparticles are being used.
Get involved with our proprietary nanoparticles
Diagnostic Imaging
Other Biomedical Applications
We supply nanoparticles that can be used in third-party branded products across hyperthermia, human and animal vaccines, and cancer screening and treatments.
Purchase SPIONS
We sell our superparamagnetic iron oxide PrecisionMRX® nanoparticles to institutions for research purposes.
Multiple coatings types are available.
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.